글로벌 네불라이저 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 통찰력

만성 호흡기 질환은 폐의 기도와 다른 부분에 영향을 미치는 질병입니다. 호흡기 증상은 일차 진료 시설에서 의사와 의사를 방문하는 가장 흔한 이유 중 하나입니다. 천식, 만성 폐쇄성 폐 질환 (COPD), 알레르기성 비염, 수면 무호흡증 및 결핵은 주요 예방 가능한 만성 호흡기 질환(주로 다중 약물 내성 결핵) 중 일부입니다. 담배 흡연은 전 세계적으로 호흡기 질환이 증가하는 주요 원인 중 하나입니다. 대도시와 산업 지역의 과도한 오염은 호흡기 질환의 유병률 증가에 기여하는 또 다른 요인입니다. 게다가, 간접 흡연 노출은 심각한 호흡기 질환을 유발합니다.

네뷸라이저 시장은 2020년에서 2029년의 예측 기간 동안 7.5%의 잠재적 시장 성장률을 기록할 것으로 예상되며 예측 기간이 끝날 때까지 13억 3천만 달러에 달할 것으로 추산됩니다. 만성 호흡기 질환의 유병률이 증가함에 따라 네뷸라이저 시장 성장이 촉진되고 있습니다.

시장 정의

네뷸라이저는 약물을 스프레이로 변환하여 폐로 직접 전달하는 데 사용되는 의료 기기의 한 유형입니다. 이는 주로 천식, 낭포성 섬유증 및 만성 폐쇄성 폐질환과 같은 폐 질환을 치료하는 데 사용됩니다. 만성 호흡기 질환의 유병률 증가는 네뷸라이저 시장의 성장을 가속화하고 있습니다.

보고 범위 및 시장 세분화

네불라이저 시장 동향

운전자

• 고령화 인구 증가

The rises in the demand for home healthcare devices, as well as the ageing population, are expected to drive the growth of the nebulizers market during the forecast period.

• Increasing technological advancements

The nebulizers market is expected to grow further as a result of technological advancements. On the other hand, the decrease in the quantity of drugs used during nebulization is expected to boost the growth of the nebulizers market over the forecast period.

Opportunities

The growing demand for home healthcare devices will provide additional opportunities for the nebulizers market to grow in the coming years.

Restraints/Challenges

The decrease in the quantity of drugs used during nebulization is also expected to impede the growth of the nebulizers market over the forecast period. In the near future, the spraying technique may pose a new challenge to the growth of the nebulizers market.

This nebulizer market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on nebulizer market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Nebulizer Market

The pandemic of COVID-19 is expected to have a significant impact on the market. Albuterol inhalers are being used more frequently in hospitals to help COVID-19 and suspected COVID-19 patients with respiratory issues. This is primarily due to the fact that respiratory viruses are the most common cause of asthma complications, and nebulizers can help provide relief. Furthermore, due to a variety of factors, including the gradual decline of immune function, older people are more vulnerable to respiratory diseases such as chronic obstructive pulmonary disease (COPD), sleep apnea, and the COVID-19.

Recent Developments

• PARI Pharma GmbH announced in March 2021 the approval of the LAMIRA Nebulizer System for the delivery of Insmed's drug product ARIKAYCE in Japan.
• AireHealth announced in December 2020 that its connected nebulizer had been cleared by the US Food and Drug Administration (FDA). The device is a portable, electronic vibrating mesh nebulizer designed to nebulize liquid medications for inhalation by patients both inside and outside the home.
• OMRON Healthcare announced the launch of its new compressor nebulizer, the OMRON NE C106, in India in July 2020.

Global Nebulizer Market Scope

The nebulizer market is segmented on the basis of product type and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Tyoe

• Ultrasonic nebulizers
• Pneumatic nebulizer
• Mesh nebulizers

On the basis of product type, the nebulizers market is segmented into ultrasonic nebulizers, pneumatic nebulizer, mesh nebulizers.

End Use

• Hospitals & clinics
• Emergency centre
• Home healthcare

On the basis of end user, the nebulizers market is segmented into hospitals & clinics, emergency centre, home healthcare.

Nebulizer Market Regional Analysis/Insights

The nebulizer market is analysed and market size insights and trends are provided by country, product type and end user as referenced above.

The countries covered in the nebulizer market report U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the nebulizers market due to technological advancements and product launches. Furthermore, the rising prevalence of respiratory disorders will drive the region's nebulizers’ market growth during the forecast period. The Asia-Pacific nebulizers market is expected to grow significantly due to an ageing population and a greater emphasis on preventive care. Furthermore, the government's initiatives to support technological innovations, as well as an increase in the use of respiratory devices, such as postoperative rooms, delivery rooms, and care units, are expected to drive the growth of the nebulizers market in the region in the coming years.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Nebulizer Market Share Analysis

네뷸라이저 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 위에 제공된 데이터 포인트는 네뷸라이저 시장과 관련된 회사의 초점에만 관련이 있습니다.

네뷸라이저 시장에서 활동하는 주요 기업으로는 Adherium(미국), AstraZeneca(영국), Boehringer Ingelheim International GmbH(독일), Cohero Health, Inc.(미국), GSK Group of Companies(영국), Teva Pharmaceutical Industries Limited(이스라엘), Vectura Group Ltd.(영국), Propeller Health(미국), Novartis AG(스위스), OPKO Health Inc.(미국), AptarGroup, Inc.(미국), Sensirion AG(스위스) 등이 있습니다.

SKU-24886